Mont-Saint-Guibert, Belgium — October 30, 2025 — Leads & Copy — Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) will release its financial results for the third quarter of 2025 on Thursday, November 13, 2025. Company management will host a conference call to discuss the results at 10:30 p.m. CET / 4:30 p.m. ET.
The conference call will be accessible via webcast through the Investor Relations page of Nyxoah’s website, with a replay available shortly after the call. Participants planning to ask questions should register at least 10 minutes prior to the call to receive dial-in details and a unique access code.
Nyxoah is a medical technology company focused on innovative solutions for Obstructive Sleep Apnea (OSA). Its lead solution, the Genio system, has received European CE Mark and U.S. FDA approval for treating OSA. The company completed IPOs on Euronext Brussels in 2020 and NASDAQ in 2021.
Rémi Renard, Chief Investor Relations and Corporate Communication Officer, can be contacted at IR@nyxoah.com.
Source: Nyxoah
